nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—L-Phenylalanine—Felbamate—epilepsy syndrome	0.37	0.635	CrCrCtD
Melphalan—L-Phenylalanine—Lacosamide—epilepsy syndrome	0.212	0.365	CrCrCtD
Melphalan—SLC22A3—Abacavir transmembrane transport—ABCG2—epilepsy syndrome	0.00497	0.0414	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—CLN8—epilepsy syndrome	0.00399	0.0332	CbGpPWpGaD
Melphalan—Chlorambucil—SLCO1A2—epilepsy syndrome	0.00391	0.485	CrCbGaD
Melphalan—SLC22A3—Abacavir transmembrane transport—ABCB1—epilepsy syndrome	0.0031	0.0258	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—PPIA—epilepsy syndrome	0.00287	0.0239	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transport and metabolism—ABCG2—epilepsy syndrome	0.00285	0.0238	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00273	0.0228	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00267	0.0222	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.0025	0.0208	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00244	0.0203	CbGpPWpGaD
Melphalan—SLC22A3—tongue—epilepsy syndrome	0.00232	0.177	CbGeAlD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00227	0.0189	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00207	0.0172	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00207	0.0172	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00198	0.0165	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00193	0.0161	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	0.00191	0.0159	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transport and metabolism—ABCB1—epilepsy syndrome	0.00178	0.0148	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—STX1B—epilepsy syndrome	0.00159	0.0132	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00157	0.0131	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00157	0.0131	CbGpPWpGaD
Melphalan—SLC7A5—telencephalon—epilepsy syndrome	0.00146	0.111	CbGeAlD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00144	0.012	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SYN1—epilepsy syndrome	0.00139	0.0116	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—NSF—epilepsy syndrome	0.00139	0.0116	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—STXBP1—epilepsy syndrome	0.00135	0.0112	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00134	0.0111	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	0.0013	0.0108	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—TEK—epilepsy syndrome	0.00129	0.0108	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—CACNA1A—epilepsy syndrome	0.00126	0.0104	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00122	0.0102	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00122	0.0102	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00122	0.0102	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SLC17A7—epilepsy syndrome	0.0012	0.01	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00118	0.00979	CbGpPWpGaD
Melphalan—L-Tyrosine—TH—epilepsy syndrome	0.00116	0.145	CrCbGaD
Melphalan—SLC7A5—medulla oblongata—epilepsy syndrome	0.00115	0.0876	CbGeAlD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00114	0.00945	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00112	0.0093	CbGpPWpGaD
Melphalan—SLC7A5—midbrain—epilepsy syndrome	0.00105	0.0801	CbGeAlD
Melphalan—SLC7A5—spinal cord—epilepsy syndrome	0.00102	0.0781	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	0.00101	0.00839	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PPIA—epilepsy syndrome	0.000956	0.00796	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SLC1A3—epilepsy syndrome	0.000951	0.00792	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000926	0.00771	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000926	0.00771	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000926	0.00771	CbGpPWpGaD
Melphalan—SLC7A5—head—epilepsy syndrome	0.000909	0.0694	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000883	0.00735	CbGpPWpGaD
Melphalan—SLC7A5—nervous system—epilepsy syndrome	0.000862	0.0658	CbGeAlD
Melphalan—SLC7A5—central nervous system—epilepsy syndrome	0.00083	0.0634	CbGeAlD
Melphalan—SLC7A5—cerebellum—epilepsy syndrome	0.000811	0.0619	CbGeAlD
Melphalan—SLC7A5—Hemostasis—DOCK7—epilepsy syndrome	0.000805	0.0067	CbGpPWpGaD
Melphalan—Ibuprofen—PLAT—epilepsy syndrome	0.000773	0.0959	CrCbGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.00072	0.00599	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000702	0.00584	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000702	0.00584	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000697	0.0058	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000697	0.0058	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—epilepsy syndrome	0.000678	0.00564	CbGpPWpGaD
Melphalan—L-Phenylalanine—TH—epilepsy syndrome	0.000676	0.0839	CrCbGaD
Melphalan—SLC7A5—brain—epilepsy syndrome	0.000659	0.0503	CbGeAlD
Melphalan—SLC7A5—Hemostasis—LAMP2—epilepsy syndrome	0.000656	0.00546	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000642	0.00534	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000622	0.00518	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000622	0.00518	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000622	0.00518	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000621	0.00517	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000621	0.00517	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000621	0.00517	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000597	0.00497	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000569	0.00474	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000568	0.00473	CbGpPWpGaD
Melphalan—SLC22A3—head—epilepsy syndrome	0.000564	0.0431	CbGeAlD
Melphalan—SLC7A5—Hemostasis—SLC8A2—epilepsy syndrome	0.000544	0.00453	CbGpPWpGaD
Melphalan—SLC22A3—nervous system—epilepsy syndrome	0.000535	0.0408	CbGeAlD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—FYN—epilepsy syndrome	0.000531	0.00442	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	0.000525	0.00437	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000525	0.00437	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SLC8A3—epilepsy syndrome	0.000519	0.00432	CbGpPWpGaD
Melphalan—SLC22A3—central nervous system—epilepsy syndrome	0.000515	0.0393	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	0.000509	0.00424	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000507	0.00422	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—epilepsy syndrome	0.000507	0.00422	CbGpPWpGaD
Melphalan—Ibuprofen—SLCO1A2—epilepsy syndrome	0.000502	0.0623	CrCbGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000496	0.00413	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000472	0.00393	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000472	0.00393	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000472	0.00393	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000471	0.00392	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000471	0.00392	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000471	0.00392	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	0.000457	0.0038	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000452	0.00376	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.00045	0.00375	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000449	0.00374	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000449	0.00374	CbGpPWpGaD
Melphalan—Ibuprofen—BCL2—epilepsy syndrome	0.000444	0.0551	CrCbGaD
Melphalan—SLC22A3—brain—epilepsy syndrome	0.000409	0.0312	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	0.000381	0.00317	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000367	0.00305	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000366	0.00305	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000357	0.00298	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000357	0.00298	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000357	0.00297	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000357	0.00297	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000355	0.00295	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000355	0.00295	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TEK—epilepsy syndrome	0.00035	0.00292	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.00034	0.00283	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—FLNA—epilepsy syndrome	0.000329	0.00274	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000327	0.00272	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000327	0.00272	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000326	0.00272	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000326	0.00272	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000326	0.00272	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000326	0.00272	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000316	0.00263	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000316	0.00263	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000316	0.00263	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KCNMA1—epilepsy syndrome	0.000312	0.0026	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SLC8A1—epilepsy syndrome	0.000308	0.00257	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000304	0.00253	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000303	0.00252	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000289	0.00241	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000289	0.00241	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000285	0.00237	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000277	0.00231	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000268	0.00223	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000267	0.00222	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000267	0.00222	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PPIA—epilepsy syndrome	0.000259	0.00216	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000258	0.00215	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000258	0.00215	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000258	0.00215	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000253	0.0021	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SRC—epilepsy syndrome	0.000247	0.00206	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000247	0.00206	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.00024	0.002	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.00024	0.002	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.00024	0.002	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ATP2A2—epilepsy syndrome	0.000237	0.00197	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.00023	0.00192	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.00023	0.00191	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ITGA2—epilepsy syndrome	0.00023	0.00191	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000229	0.0019	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000229	0.0019	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.00021	0.00175	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000205	0.00171	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ADRA2A—epilepsy syndrome	0.000202	0.00168	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLAT—epilepsy syndrome	0.000201	0.00167	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CA13—epilepsy syndrome	0.000195	0.00163	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS1—epilepsy syndrome	0.000189	0.00157	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000186	0.00155	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000182	0.00151	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000182	0.00151	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT3—epilepsy syndrome	0.000177	0.00147	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLAUR—epilepsy syndrome	0.000175	0.00146	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000174	0.00145	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000173	0.00144	CbGpPWpGaD
Melphalan—Anaemia—Valproic Acid—epilepsy syndrome	0.00017	0.000613	CcSEcCtD
Melphalan—Urticaria—Zonisamide—epilepsy syndrome	0.00017	0.000613	CcSEcCtD
Melphalan—Decreased appetite—Carbamazepine—epilepsy syndrome	0.00017	0.000613	CcSEcCtD
Melphalan—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000169	0.000612	CcSEcCtD
Melphalan—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000169	0.00061	CcSEcCtD
Melphalan—Asthenia—Fosphenytoin—epilepsy syndrome	0.000168	0.000609	CcSEcCtD
Melphalan—Alopecia—Pregabalin—epilepsy syndrome	0.000168	0.000609	CcSEcCtD
Melphalan—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000168	0.000609	CcSEcCtD
Melphalan—Fatigue—Carbamazepine—epilepsy syndrome	0.000168	0.000608	CcSEcCtD
Melphalan—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000168	0.000608	CcSEcCtD
Melphalan—Ibuprofen—CYP2C19—epilepsy syndrome	0.000167	0.0207	CrCbGaD
Melphalan—Pain—Carbamazepine—epilepsy syndrome	0.000167	0.000603	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000167	0.00139	CbGpPWpGaD
Melphalan—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000166	0.000602	CcSEcCtD
Melphalan—Pruritus—Fosphenytoin—epilepsy syndrome	0.000166	0.000601	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000166	0.00138	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000166	0.00138	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000166	0.00138	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000166	0.00138	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000166	0.00138	CbGpPWpGaD
Melphalan—Hypersensitivity—Diazepam—epilepsy syndrome	0.000166	0.0006	CcSEcCtD
Melphalan—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000166	0.0006	CcSEcCtD
Melphalan—Leukopenia—Valproic Acid—epilepsy syndrome	0.000164	0.000594	CcSEcCtD
Melphalan—Asthenia—Vigabatrin—epilepsy syndrome	0.000164	0.000594	CcSEcCtD
Melphalan—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000164	0.000593	CcSEcCtD
Melphalan—Urticaria—Clonazepam—epilepsy syndrome	0.000163	0.000591	CcSEcCtD
Melphalan—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000163	0.000589	CcSEcCtD
Melphalan—Fatigue—Lamotrigine—epilepsy syndrome	0.000163	0.000588	CcSEcCtD
Melphalan—Urticaria—Phenytoin—epilepsy syndrome	0.000162	0.000587	CcSEcCtD
Melphalan—Pruritus—Vigabatrin—epilepsy syndrome	0.000162	0.000586	CcSEcCtD
Melphalan—Asthenia—Diazepam—epilepsy syndrome	0.000162	0.000585	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—CDC42—epilepsy syndrome	0.000162	0.00135	CbGpPWpGaD
Melphalan—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000162	0.000584	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000161	0.00134	CbGpPWpGaD
Melphalan—Pain—Lamotrigine—epilepsy syndrome	0.000161	0.000583	CcSEcCtD
Melphalan—Nausea—Acetazolamide—epilepsy syndrome	0.000161	0.000582	CcSEcCtD
Melphalan—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000161	0.000581	CcSEcCtD
Melphalan—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000161	0.000581	CcSEcCtD
Melphalan—Cough—Valproic Acid—epilepsy syndrome	0.00016	0.000579	CcSEcCtD
Melphalan—Vomiting—Propofol—epilepsy syndrome	0.00016	0.000579	CcSEcCtD
Melphalan—Stomatitis—Topiramate—epilepsy syndrome	0.00016	0.000577	CcSEcCtD
Melphalan—Pruritus—Diazepam—epilepsy syndrome	0.000159	0.000576	CcSEcCtD
Melphalan—Rash—Propofol—epilepsy syndrome	0.000159	0.000574	CcSEcCtD
Melphalan—Dermatitis—Propofol—epilepsy syndrome	0.000159	0.000574	CcSEcCtD
Melphalan—Immune system disorder—Gabapentin—epilepsy syndrome	0.000158	0.000571	CcSEcCtD
Melphalan—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000158	0.00057	CcSEcCtD
Melphalan—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000157	0.000569	CcSEcCtD
Melphalan—Vomiting—Midazolam—epilepsy syndrome	0.000157	0.000566	CcSEcCtD
Melphalan—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000157	0.000566	CcSEcCtD
Melphalan—Asthenia—Felbamate—epilepsy syndrome	0.000156	0.000566	CcSEcCtD
Melphalan—Myalgia—Valproic Acid—epilepsy syndrome	0.000156	0.000565	CcSEcCtD
Melphalan—Chest pain—Valproic Acid—epilepsy syndrome	0.000156	0.000565	CcSEcCtD
Melphalan—Rash—Midazolam—epilepsy syndrome	0.000155	0.000562	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000155	0.000561	CcSEcCtD
Melphalan—Dermatitis—Midazolam—epilepsy syndrome	0.000155	0.000561	CcSEcCtD
Melphalan—Urticaria—Carbamazepine—epilepsy syndrome	0.000155	0.00056	CcSEcCtD
Melphalan—Vomiting—Levetiracetam—epilepsy syndrome	0.000155	0.000559	CcSEcCtD
Melphalan—Alopecia—Gabapentin—epilepsy syndrome	0.000154	0.000559	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000154	0.00129	CbGpPWpGaD
Melphalan—Pruritus—Felbamate—epilepsy syndrome	0.000154	0.000558	CcSEcCtD
Melphalan—Diarrhoea—Diazepam—epilepsy syndrome	0.000154	0.000557	CcSEcCtD
Melphalan—Rash—Levetiracetam—epilepsy syndrome	0.000153	0.000555	CcSEcCtD
Melphalan—Anaemia—Pregabalin—epilepsy syndrome	0.000153	0.000555	CcSEcCtD
Melphalan—Dermatitis—Levetiracetam—epilepsy syndrome	0.000153	0.000554	CcSEcCtD
Melphalan—Asthenia—Zonisamide—epilepsy syndrome	0.000153	0.000554	CcSEcCtD
Melphalan—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000152	0.000548	CcSEcCtD
Melphalan—Pruritus—Zonisamide—epilepsy syndrome	0.000151	0.000546	CcSEcCtD
Melphalan—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000151	0.000544	CcSEcCtD
Melphalan—Oedema—Valproic Acid—epilepsy syndrome	0.00015	0.000542	CcSEcCtD
Melphalan—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.00015	0.000542	CcSEcCtD
Melphalan—Urticaria—Lamotrigine—epilepsy syndrome	0.00015	0.000542	CcSEcCtD
Melphalan—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00015	0.000542	CcSEcCtD
Melphalan—Nausea—Propofol—epilepsy syndrome	0.00015	0.000541	CcSEcCtD
Melphalan—Vomiting—Fosphenytoin—epilepsy syndrome	0.000149	0.00054	CcSEcCtD
Melphalan—Diarrhoea—Felbamate—epilepsy syndrome	0.000149	0.00054	CcSEcCtD
Melphalan—Infection—Valproic Acid—epilepsy syndrome	0.000149	0.000538	CcSEcCtD
Melphalan—Leukopenia—Pregabalin—epilepsy syndrome	0.000149	0.000537	CcSEcCtD
Melphalan—SLC22A3—Metabolism—FAR1—epilepsy syndrome	0.000148	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GLUD1—epilepsy syndrome	0.000148	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—L2HGDH—epilepsy syndrome	0.000148	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ADK—epilepsy syndrome	0.000148	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PDXK—epilepsy syndrome	0.000148	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CERS1—epilepsy syndrome	0.000148	0.00123	CbGpPWpGaD
Melphalan—Rash—Fosphenytoin—epilepsy syndrome	0.000148	0.000535	CcSEcCtD
Melphalan—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000148	0.000535	CcSEcCtD
Melphalan—Haemoglobin—Topiramate—epilepsy syndrome	0.000148	0.000534	CcSEcCtD
Melphalan—Asthenia—Clonazepam—epilepsy syndrome	0.000148	0.000534	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000147	0.00123	CbGpPWpGaD
Melphalan—Haemorrhage—Topiramate—epilepsy syndrome	0.000147	0.000532	CcSEcCtD
Melphalan—Hepatitis—Topiramate—epilepsy syndrome	0.000147	0.000532	CcSEcCtD
Melphalan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000147	0.00053	CcSEcCtD
Melphalan—Asthenia—Phenytoin—epilepsy syndrome	0.000147	0.00053	CcSEcCtD
Melphalan—Nausea—Midazolam—epilepsy syndrome	0.000146	0.000529	CcSEcCtD
Melphalan—Tachycardia—Valproic Acid—epilepsy syndrome	0.000146	0.000529	CcSEcCtD
Melphalan—Diarrhoea—Zonisamide—epilepsy syndrome	0.000146	0.000528	CcSEcCtD
Melphalan—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000146	0.000527	CcSEcCtD
Melphalan—Pruritus—Clonazepam—epilepsy syndrome	0.000146	0.000526	CcSEcCtD
Melphalan—Vomiting—Vigabatrin—epilepsy syndrome	0.000146	0.000526	CcSEcCtD
Melphalan—Skin disorder—Valproic Acid—epilepsy syndrome	0.000146	0.000526	CcSEcCtD
Melphalan—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000145	0.000525	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000145	0.00121	CbGpPWpGaD
Melphalan—Cough—Pregabalin—epilepsy syndrome	0.000145	0.000524	CcSEcCtD
Melphalan—Pruritus—Phenytoin—epilepsy syndrome	0.000145	0.000523	CcSEcCtD
Melphalan—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000145	0.000523	CcSEcCtD
Melphalan—Nausea—Levetiracetam—epilepsy syndrome	0.000145	0.000523	CcSEcCtD
Melphalan—Rash—Vigabatrin—epilepsy syndrome	0.000144	0.000522	CcSEcCtD
Melphalan—Dermatitis—Vigabatrin—epilepsy syndrome	0.000144	0.000521	CcSEcCtD
Melphalan—Urethral disorder—Topiramate—epilepsy syndrome	0.000144	0.000521	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—FYN—epilepsy syndrome	0.000144	0.0012	CbGpPWpGaD
Melphalan—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000144	0.00052	CcSEcCtD
Melphalan—Convulsion—Pregabalin—epilepsy syndrome	0.000144	0.00052	CcSEcCtD
Melphalan—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000144	0.00052	CcSEcCtD
Melphalan—Vomiting—Diazepam—epilepsy syndrome	0.000143	0.000518	CcSEcCtD
Melphalan—Anorexia—Valproic Acid—epilepsy syndrome	0.000143	0.000516	CcSEcCtD
Melphalan—Rash—Diazepam—epilepsy syndrome	0.000142	0.000514	CcSEcCtD
Melphalan—Dermatitis—Diazepam—epilepsy syndrome	0.000142	0.000513	CcSEcCtD
Melphalan—L-DOPA—CYP2D6—epilepsy syndrome	0.000142	0.0176	CrCbGaD
Melphalan—Chest pain—Pregabalin—epilepsy syndrome	0.000141	0.000511	CcSEcCtD
Melphalan—Myalgia—Pregabalin—epilepsy syndrome	0.000141	0.000511	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000141	0.00118	CbGpPWpGaD
Melphalan—Diarrhoea—Clonazepam—epilepsy syndrome	0.000141	0.000509	CcSEcCtD
Melphalan—Anaemia—Gabapentin—epilepsy syndrome	0.000141	0.000509	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.00014	0.000507	CcSEcCtD
Melphalan—Hypotension—Valproic Acid—epilepsy syndrome	0.00014	0.000506	CcSEcCtD
Melphalan—Asthenia—Carbamazepine—epilepsy syndrome	0.00014	0.000506	CcSEcCtD
Melphalan—Diarrhoea—Phenytoin—epilepsy syndrome	0.00014	0.000506	CcSEcCtD
Melphalan—Nausea—Fosphenytoin—epilepsy syndrome	0.000139	0.000504	CcSEcCtD
Melphalan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000139	0.000503	CcSEcCtD
Melphalan—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000139	0.000502	CcSEcCtD
Melphalan—Vomiting—Felbamate—epilepsy syndrome	0.000139	0.000501	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—YWHAZ—epilepsy syndrome	0.000138	0.00115	CbGpPWpGaD
Melphalan—Pruritus—Carbamazepine—epilepsy syndrome	0.000138	0.000499	CcSEcCtD
Melphalan—Rash—Felbamate—epilepsy syndrome	0.000138	0.000497	CcSEcCtD
Melphalan—Dermatitis—Felbamate—epilepsy syndrome	0.000137	0.000497	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000137	0.00114	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000137	0.000494	CcSEcCtD
Melphalan—Flushing—Topiramate—epilepsy syndrome	0.000137	0.000494	CcSEcCtD
Melphalan—Leukopenia—Gabapentin—epilepsy syndrome	0.000136	0.000493	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000136	0.00113	CbGpPWpGaD
Melphalan—Nausea—Vigabatrin—epilepsy syndrome	0.000136	0.000492	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000136	0.00113	CbGpPWpGaD
Melphalan—Vomiting—Zonisamide—epilepsy syndrome	0.000136	0.000491	CcSEcCtD
Melphalan—SLC22A3—Metabolism—PNPO—epilepsy syndrome	0.000135	0.00113	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—EPM2A—epilepsy syndrome	0.000135	0.00113	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NHLRC1—epilepsy syndrome	0.000135	0.00113	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GAMT—epilepsy syndrome	0.000135	0.00113	CbGpPWpGaD
Melphalan—Oedema—Pregabalin—epilepsy syndrome	0.000135	0.00049	CcSEcCtD
Melphalan—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000135	0.00049	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000135	0.00113	CbGpPWpGaD
Melphalan—Asthenia—Lamotrigine—epilepsy syndrome	0.000135	0.000489	CcSEcCtD
Melphalan—Rash—Zonisamide—epilepsy syndrome	0.000135	0.000487	CcSEcCtD
Melphalan—Infection—Pregabalin—epilepsy syndrome	0.000135	0.000487	CcSEcCtD
Melphalan—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000135	0.000486	CcSEcCtD
Melphalan—Dermatitis—Zonisamide—epilepsy syndrome	0.000134	0.000486	CcSEcCtD
Melphalan—Nausea—Diazepam—epilepsy syndrome	0.000134	0.000484	CcSEcCtD
Melphalan—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000134	0.000483	CcSEcCtD
Melphalan—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000133	0.000483	CcSEcCtD
Melphalan—Pruritus—Lamotrigine—epilepsy syndrome	0.000133	0.000482	CcSEcCtD
Melphalan—Immune system disorder—Topiramate—epilepsy syndrome	0.000133	0.00048	CcSEcCtD
Melphalan—Cough—Gabapentin—epilepsy syndrome	0.000133	0.00048	CcSEcCtD
Melphalan—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000133	0.00048	CcSEcCtD
Melphalan—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000133	0.000479	CcSEcCtD
Melphalan—Tachycardia—Pregabalin—epilepsy syndrome	0.000132	0.000478	CcSEcCtD
Melphalan—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000132	0.000477	CcSEcCtD
Melphalan—Convulsion—Gabapentin—epilepsy syndrome	0.000132	0.000477	CcSEcCtD
Melphalan—Skin disorder—Pregabalin—epilepsy syndrome	0.000132	0.000476	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000131	0.00109	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000131	0.00109	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000131	0.00109	CbGpPWpGaD
Melphalan—Vomiting—Clonazepam—epilepsy syndrome	0.000131	0.000473	CcSEcCtD
Melphalan—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00013	0.000471	CcSEcCtD
Melphalan—Alopecia—Topiramate—epilepsy syndrome	0.00013	0.00047	CcSEcCtD
Melphalan—Vomiting—Phenytoin—epilepsy syndrome	0.00013	0.00047	CcSEcCtD
Melphalan—Rash—Clonazepam—epilepsy syndrome	0.00013	0.000469	CcSEcCtD
Melphalan—Dermatitis—Clonazepam—epilepsy syndrome	0.00013	0.000469	CcSEcCtD
Melphalan—Chest pain—Gabapentin—epilepsy syndrome	0.00013	0.000468	CcSEcCtD
Melphalan—Myalgia—Gabapentin—epilepsy syndrome	0.00013	0.000468	CcSEcCtD
Melphalan—Nausea—Felbamate—epilepsy syndrome	0.00013	0.000468	CcSEcCtD
Melphalan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000129	0.000468	CcSEcCtD
Melphalan—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000129	0.000467	CcSEcCtD
Melphalan—Fatigue—Valproic Acid—epilepsy syndrome	0.000129	0.000467	CcSEcCtD
Melphalan—Anorexia—Pregabalin—epilepsy syndrome	0.000129	0.000467	CcSEcCtD
Melphalan—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000129	0.000466	CcSEcCtD
Melphalan—Rash—Phenytoin—epilepsy syndrome	0.000129	0.000466	CcSEcCtD
Melphalan—Dermatitis—Phenytoin—epilepsy syndrome	0.000129	0.000466	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000129	0.000465	CcSEcCtD
Melphalan—Rash—Oxcarbazepine—epilepsy syndrome	0.000128	0.000463	CcSEcCtD
Melphalan—Pain—Valproic Acid—epilepsy syndrome	0.000128	0.000463	CcSEcCtD
Melphalan—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000128	0.000463	CcSEcCtD
Melphalan—Nausea—Zonisamide—epilepsy syndrome	0.000127	0.000459	CcSEcCtD
Melphalan—Hypotension—Pregabalin—epilepsy syndrome	0.000127	0.000458	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CA4—epilepsy syndrome	0.000126	0.00105	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—QDPR—epilepsy syndrome	0.000126	0.00105	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000126	0.00105	CbGpPWpGaD
Melphalan—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000124	0.000449	CcSEcCtD
Melphalan—Oedema—Gabapentin—epilepsy syndrome	0.000124	0.000449	CcSEcCtD
Melphalan—Vomiting—Carbamazepine—epilepsy syndrome	0.000124	0.000448	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000123	0.000446	CcSEcCtD
Melphalan—Infection—Gabapentin—epilepsy syndrome	0.000123	0.000446	CcSEcCtD
Melphalan—Rash—Carbamazepine—epilepsy syndrome	0.000123	0.000445	CcSEcCtD
Melphalan—Dermatitis—Carbamazepine—epilepsy syndrome	0.000123	0.000444	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PLAU—epilepsy syndrome	0.000123	0.00102	CbGpPWpGaD
Melphalan—Nausea—Clonazepam—epilepsy syndrome	0.000122	0.000442	CcSEcCtD
Melphalan—Paraesthesia—Pregabalin—epilepsy syndrome	0.000122	0.00044	CcSEcCtD
Melphalan—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000122	0.00044	CcSEcCtD
Melphalan—Nausea—Phenytoin—epilepsy syndrome	0.000121	0.000439	CcSEcCtD
Melphalan—Tachycardia—Gabapentin—epilepsy syndrome	0.000121	0.000438	CcSEcCtD
Melphalan—Dyspnoea—Pregabalin—epilepsy syndrome	0.000121	0.000437	CcSEcCtD
Melphalan—Nausea—Oxcarbazepine—epilepsy syndrome	0.000121	0.000437	CcSEcCtD
Melphalan—Skin disorder—Gabapentin—epilepsy syndrome	0.000121	0.000436	CcSEcCtD
Melphalan—Vomiting—Lamotrigine—epilepsy syndrome	0.00012	0.000433	CcSEcCtD
Melphalan—Urticaria—Valproic Acid—epilepsy syndrome	0.000119	0.00043	CcSEcCtD
Melphalan—Rash—Lamotrigine—epilepsy syndrome	0.000119	0.00043	CcSEcCtD
Melphalan—Dermatitis—Lamotrigine—epilepsy syndrome	0.000119	0.000429	CcSEcCtD
Melphalan—SLC22A3—Metabolism—COX3—epilepsy syndrome	0.000118	0.000986	CbGpPWpGaD
Melphalan—Anorexia—Gabapentin—epilepsy syndrome	0.000118	0.000428	CcSEcCtD
Melphalan—Anaemia—Topiramate—epilepsy syndrome	0.000118	0.000428	CcSEcCtD
Melphalan—Decreased appetite—Pregabalin—epilepsy syndrome	0.000118	0.000426	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000117	0.000974	CbGpPWpGaD
Melphalan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000117	0.000423	CcSEcCtD
Melphalan—Fatigue—Pregabalin—epilepsy syndrome	0.000117	0.000422	CcSEcCtD
Melphalan—Hypotension—Gabapentin—epilepsy syndrome	0.000116	0.00042	CcSEcCtD
Melphalan—Nausea—Carbamazepine—epilepsy syndrome	0.000116	0.000419	CcSEcCtD
Melphalan—Pain—Pregabalin—epilepsy syndrome	0.000116	0.000419	CcSEcCtD
Melphalan—Leukopenia—Topiramate—epilepsy syndrome	0.000115	0.000414	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PRKCB—epilepsy syndrome	0.000114	0.00095	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000113	0.000409	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—NOS2—epilepsy syndrome	0.000113	0.000939	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—KCNB1—epilepsy syndrome	0.000112	0.000935	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CACNA2D2—epilepsy syndrome	0.000112	0.000935	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PFKL—epilepsy syndrome	0.000112	0.000935	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLCO1A2—epilepsy syndrome	0.000112	0.000935	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC6A8—epilepsy syndrome	0.000112	0.000935	CbGpPWpGaD
Melphalan—Nausea—Lamotrigine—epilepsy syndrome	0.000112	0.000405	CcSEcCtD
Melphalan—Cough—Topiramate—epilepsy syndrome	0.000112	0.000404	CcSEcCtD
Melphalan—Paraesthesia—Gabapentin—epilepsy syndrome	0.000112	0.000403	CcSEcCtD
Melphalan—Convulsion—Topiramate—epilepsy syndrome	0.000111	0.000401	CcSEcCtD
Melphalan—Dyspnoea—Gabapentin—epilepsy syndrome	0.000111	0.0004	CcSEcCtD
Melphalan—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00011	0.000399	CcSEcCtD
Melphalan—Dyspepsia—Gabapentin—epilepsy syndrome	0.000109	0.000395	CcSEcCtD
Melphalan—Myalgia—Topiramate—epilepsy syndrome	0.000109	0.000394	CcSEcCtD
Melphalan—Chest pain—Topiramate—epilepsy syndrome	0.000109	0.000394	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000108	0.000391	CcSEcCtD
Melphalan—Decreased appetite—Gabapentin—epilepsy syndrome	0.000108	0.00039	CcSEcCtD
Melphalan—Urticaria—Pregabalin—epilepsy syndrome	0.000108	0.000389	CcSEcCtD
Melphalan—Asthenia—Valproic Acid—epilepsy syndrome	0.000107	0.000389	CcSEcCtD
Melphalan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000107	0.000388	CcSEcCtD
Melphalan—Fatigue—Gabapentin—epilepsy syndrome	0.000107	0.000387	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000107	0.000891	CbGpPWpGaD
Melphalan—Pain—Gabapentin—epilepsy syndrome	0.000106	0.000384	CcSEcCtD
Melphalan—Pruritus—Valproic Acid—epilepsy syndrome	0.000106	0.000383	CcSEcCtD
Melphalan—Oedema—Topiramate—epilepsy syndrome	0.000104	0.000378	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000104	0.000869	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS2—epilepsy syndrome	0.000104	0.0129	CrCbGaD
Melphalan—Infection—Topiramate—epilepsy syndrome	0.000104	0.000375	CcSEcCtD
Melphalan—SLC22A3—Metabolism—UPB1—epilepsy syndrome	0.000103	0.000855	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ATIC—epilepsy syndrome	0.000103	0.000855	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NEU1—epilepsy syndrome	0.000103	0.000855	CbGpPWpGaD
Melphalan—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000103	0.000371	CcSEcCtD
Melphalan—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000102	0.00037	CcSEcCtD
Melphalan—Tachycardia—Topiramate—epilepsy syndrome	0.000102	0.000369	CcSEcCtD
Melphalan—Skin disorder—Topiramate—epilepsy syndrome	0.000101	0.000367	CcSEcCtD
Melphalan—Hypersensitivity—Pregabalin—epilepsy syndrome	9.98e-05	0.000361	CcSEcCtD
Melphalan—Anorexia—Topiramate—epilepsy syndrome	9.96e-05	0.00036	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HSD17B4—epilepsy syndrome	9.88e-05	0.000823	CbGpPWpGaD
Melphalan—Urticaria—Gabapentin—epilepsy syndrome	9.87e-05	0.000357	CcSEcCtD
Melphalan—Hypotension—Topiramate—epilepsy syndrome	9.76e-05	0.000353	CcSEcCtD
Melphalan—Asthenia—Pregabalin—epilepsy syndrome	9.72e-05	0.000351	CcSEcCtD
Melphalan—Pruritus—Pregabalin—epilepsy syndrome	9.58e-05	0.000346	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GBE1—epilepsy syndrome	9.55e-05	0.000795	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPP1R3C—epilepsy syndrome	9.55e-05	0.000795	CbGpPWpGaD
Melphalan—Vomiting—Valproic Acid—epilepsy syndrome	9.53e-05	0.000344	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.52e-05	0.000344	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ALB—epilepsy syndrome	9.48e-05	0.000789	CbGpPWpGaD
Melphalan—Rash—Valproic Acid—epilepsy syndrome	9.45e-05	0.000342	CcSEcCtD
Melphalan—Dermatitis—Valproic Acid—epilepsy syndrome	9.44e-05	0.000341	CcSEcCtD
Melphalan—Paraesthesia—Topiramate—epilepsy syndrome	9.38e-05	0.000339	CcSEcCtD
Melphalan—Dyspnoea—Topiramate—epilepsy syndrome	9.32e-05	0.000337	CcSEcCtD
Melphalan—Diarrhoea—Pregabalin—epilepsy syndrome	9.27e-05	0.000335	CcSEcCtD
Melphalan—Ibuprofen—ALB—epilepsy syndrome	9.26e-05	0.0115	CrCbGaD
Melphalan—Dyspepsia—Topiramate—epilepsy syndrome	9.2e-05	0.000333	CcSEcCtD
Melphalan—Hypersensitivity—Gabapentin—epilepsy syndrome	9.15e-05	0.000331	CcSEcCtD
Melphalan—Decreased appetite—Topiramate—epilepsy syndrome	9.08e-05	0.000328	CcSEcCtD
Melphalan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.02e-05	0.000326	CcSEcCtD
Melphalan—Fatigue—Topiramate—epilepsy syndrome	9.01e-05	0.000326	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ASAH1—epilepsy syndrome	8.97e-05	0.000747	CbGpPWpGaD
Melphalan—Pain—Topiramate—epilepsy syndrome	8.94e-05	0.000323	CcSEcCtD
Melphalan—Asthenia—Gabapentin—epilepsy syndrome	8.91e-05	0.000322	CcSEcCtD
Melphalan—Nausea—Valproic Acid—epilepsy syndrome	8.9e-05	0.000322	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.87e-05	0.000738	CbGpPWpGaD
Melphalan—Ibuprofen—ABCB1—epilepsy syndrome	8.83e-05	0.011	CrCbGaD
Melphalan—Pruritus—Gabapentin—epilepsy syndrome	8.79e-05	0.000318	CcSEcCtD
Melphalan—SLC22A3—Metabolism—STXBP1—epilepsy syndrome	8.73e-05	0.000727	CbGpPWpGaD
Melphalan—Vomiting—Pregabalin—epilepsy syndrome	8.61e-05	0.000311	CcSEcCtD
Melphalan—Rash—Pregabalin—epilepsy syndrome	8.54e-05	0.000309	CcSEcCtD
Melphalan—Dermatitis—Pregabalin—epilepsy syndrome	8.53e-05	0.000309	CcSEcCtD
Melphalan—SLC22A3—Metabolism—NT5E—epilepsy syndrome	8.51e-05	0.000708	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALAD—epilepsy syndrome	8.51e-05	0.000708	CbGpPWpGaD
Melphalan—Diarrhoea—Gabapentin—epilepsy syndrome	8.5e-05	0.000307	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.46e-05	0.000704	CbGpPWpGaD
Melphalan—Urticaria—Topiramate—epilepsy syndrome	8.3e-05	0.0003	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	8.22e-05	0.000685	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.21e-05	0.000683	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CACNA1A—epilepsy syndrome	8.12e-05	0.000676	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALDH7A1—epilepsy syndrome	8.12e-05	0.000676	CbGpPWpGaD
Melphalan—Nausea—Pregabalin—epilepsy syndrome	8.05e-05	0.000291	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ST3GAL3—epilepsy syndrome	7.94e-05	0.000661	CbGpPWpGaD
Melphalan—Vomiting—Gabapentin—epilepsy syndrome	7.9e-05	0.000286	CcSEcCtD
Melphalan—Rash—Gabapentin—epilepsy syndrome	7.83e-05	0.000283	CcSEcCtD
Melphalan—Dermatitis—Gabapentin—epilepsy syndrome	7.82e-05	0.000283	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ADSL—epilepsy syndrome	7.78e-05	0.000648	CbGpPWpGaD
Melphalan—Hypersensitivity—Topiramate—epilepsy syndrome	7.7e-05	0.000278	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GLUL—epilepsy syndrome	7.63e-05	0.000635	CbGpPWpGaD
Melphalan—Asthenia—Topiramate—epilepsy syndrome	7.5e-05	0.000271	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CACNA1D—epilepsy syndrome	7.49e-05	0.000624	CbGpPWpGaD
Melphalan—Pruritus—Topiramate—epilepsy syndrome	7.39e-05	0.000267	CcSEcCtD
Melphalan—Nausea—Gabapentin—epilepsy syndrome	7.38e-05	0.000267	CcSEcCtD
Melphalan—Diarrhoea—Topiramate—epilepsy syndrome	7.15e-05	0.000259	CcSEcCtD
Melphalan—SLC22A3—Metabolism—TXNRD1—epilepsy syndrome	7.01e-05	0.000583	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.96e-05	0.000579	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.9e-05	0.000574	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AQP1—epilepsy syndrome	6.8e-05	0.000566	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SRC—epilepsy syndrome	6.71e-05	0.000558	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.68e-05	0.000556	CbGpPWpGaD
Melphalan—Vomiting—Topiramate—epilepsy syndrome	6.64e-05	0.00024	CcSEcCtD
Melphalan—Rash—Topiramate—epilepsy syndrome	6.59e-05	0.000238	CcSEcCtD
Melphalan—Dermatitis—Topiramate—epilepsy syndrome	6.58e-05	0.000238	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—VEGFA—epilepsy syndrome	6.53e-05	0.000544	CbGpPWpGaD
Melphalan—Nausea—Topiramate—epilepsy syndrome	6.21e-05	0.000224	CcSEcCtD
Melphalan—SLC22A3—Metabolism—KCNJ11—epilepsy syndrome	6.15e-05	0.000512	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CHRM3—epilepsy syndrome	6.15e-05	0.000512	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCG2—epilepsy syndrome	5.01e-05	0.000417	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2C19—epilepsy syndrome	4.89e-05	0.000407	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP11A1—epilepsy syndrome	4.86e-05	0.000404	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2D6—epilepsy syndrome	4.38e-05	0.000365	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.18e-05	0.000348	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ADRA2A—epilepsy syndrome	4.17e-05	0.000347	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT1—epilepsy syndrome	4.17e-05	0.000347	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BCHE—epilepsy syndrome	4.15e-05	0.000346	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC2A1—epilepsy syndrome	3.96e-05	0.00033	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLCB1—epilepsy syndrome	3.92e-05	0.000326	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—TH—epilepsy syndrome	3.91e-05	0.000325	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HMOX1—epilepsy syndrome	3.26e-05	0.000271	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAT—epilepsy syndrome	3.22e-05	0.000268	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCB1—epilepsy syndrome	3.13e-05	0.000261	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPX1—epilepsy syndrome	2.91e-05	0.000242	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AGT—epilepsy syndrome	2.55e-05	0.000212	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOE—epilepsy syndrome	2.5e-05	0.000208	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—POMC—epilepsy syndrome	2.15e-05	0.000179	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—epilepsy syndrome	1.96e-05	0.000163	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—epilepsy syndrome	1.71e-05	0.000143	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKT1—epilepsy syndrome	8.61e-06	7.17e-05	CbGpPWpGaD
